000779164 000__ 05380cam\a2200493Ii\4500
000779164 001__ 779164
000779164 005__ 20230306142914.0
000779164 006__ m\\\\\o\\d\\\\\\\\
000779164 007__ cr\nn\nnnunnun
000779164 008__ 170126s2017\\\\sz\\\\\\o\\\\\001\0\eng\d
000779164 019__ $$a974651258$$a981034139$$a981776572$$a986455399
000779164 020__ $$a9783319475189$$q(electronic book)
000779164 020__ $$a3319475185$$q(electronic book)
000779164 020__ $$z9783319475172
000779164 0247_ $$a10.1007/978-3-319-47518-9$$2doi
000779164 035__ $$aSP(OCoLC)ocn970041798
000779164 035__ $$aSP(OCoLC)970041798$$z(OCoLC)974651258$$z(OCoLC)981034139$$z(OCoLC)981776572$$z(OCoLC)986455399
000779164 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dN$T$$dIDEBK$$dOCLCF$$dUAB$$dCOO$$dUPM$$dVT2$$dIOG
000779164 049__ $$aISEA
000779164 050_4 $$aRC606.6
000779164 08204 $$a616.97/9206$$223
000779164 24504 $$aThe CAPRISA clinical trials :$$bHIV treatment and prevention /$$cQuarraisha Abdool Karim, Salim S. Abdool Karim, Cheryl Baxter, editors.
000779164 264_1 $$aCham, Switzerland :$$bSpringer,$$c2017.
000779164 300__ $$a1 online resource.
000779164 336__ $$atext$$btxt$$2rdacontent
000779164 337__ $$acomputer$$bc$$2rdamedia
000779164 338__ $$aonline resource$$bcr$$2rdacarrier
000779164 347__ $$atext file$$bPDF$$2rda
000779164 500__ $$aIncludes index.
000779164 5050_ $$aPart I. Introduction -- Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda -- CAPRISA: Establishing A Research Center to Undertake HIV Clinical Trials -- Overview of Clinical Trials -- Part II. CAPRISA Clinical Trials for HIV and HSV-2 Prevention -- Antiretrovirals for HIV Prevention -- Rolling out of tenofovir gel in family planning clinics: the CAPRISA 008 implementation trial -- Conditional cash transfers to reduce HIV risk in young women: the CAPRISA 007 cluster randomised control trial -- HIV vaccine and passive immunity trials -- Part III: CAPRISA Clinical Trials for HIV?TB Treatment -- CAPRISA 003: Timing of antiretroviral initiation in HIV-TB co-infected patients -- The SAPiT Trial -- Scaling up TB-HIV integration in public health clinics: translating research findings into practice -- Part IV: Experiences and lessons learnt from clinical trials in CAPRISA -- Lessons from the Acute Infection Study: from Bench to Bedside -- Understanding sexual HIV transmission in women by focusing on the genital mucosa -- Part V: Essential support activities for the conduct of clinical trials -- Good practices in conducting clinical trials: Good Participatory Practice, Good Pharmacy Practice and Good Laboratory Practice -- Grants Management -- Taking science to the people: communication and media strategies for clinical trials -- Looking ahead: What Does the Future Hold for CAPRISA? -- Appendix -- Index. .
000779164 506__ $$aAccess limited to authorized users.
000779164 520__ $$aSince its inception 14 years ago, CAPRISA has conducted numerous clinical studies that have influenced international TB-HIV treatment guidelines as well as HIV prevention through innovations in the microbicide and vaccine fields. This book provides a historical account of how each of CAPRISA?s high impact studies was created, developed, implemented, analysed and communicated. In doing so, the reader is taken on a journey that provides glimpses into the genesis of research ideas and how this ultimately leads to a range of HIV prevention and treatment studies that have impacted the global response to the HIV and TB epidemics. Comprised of 5 sections, the book details the following: HIV epidemic in South Africa and the establishment of a research centre to undertake clinical, epidemiological and laboratory research on HIV. CAPRISA?s clinical trials on HIV and HSV-2 prevention. These studies investigated the impact of tenofovir gel as topical antiretroviral pre-exposure prophylaxis (PrEP), implementation of topical PrEP through family planning clinics, conditional cash incentives for HIV prevention, HIV vaccines, and passive immunisation with broadly neutralising antibodies. CAPRISA?s research on the treatment of HIV and TB co-infection. A review of the major scientific findings from the CAPRISA studies on acute infection and genital mucosal immunology. Essential support activities for the conduct of clinical trials, including research laboratories and pharmacies, as well as establishing effective communication and sustainable structures for community engagement to maintain effective and respectful partnerships with participating communities. The book concludes with a chapter about the challenges facing future HIV prevention and treatment trials. The CAPRISA Clinical Trials: HIV Treatment and Prevention is a resource for undergraduate and postgraduate students, health care providers, doctors, decision-makers and researchers who are seeking guidance and insights on clinical trials ? their creation, conduct and impact.
000779164 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 30, 2017).
000779164 650_0 $$aHIV infections$$xTreatment.
000779164 650_0 $$aHIV infections$$xPrevention.
000779164 650_0 $$aClinical trials.
000779164 7001_ $$aAbdool Karim, Q.$$q(Quarraisha),$$eeditor.
000779164 7001_ $$aKarim, Salim S. Abdool,$$eeditor.
000779164 7001_ $$aBaxter, Cheryl,$$eeditor.
000779164 77608 $$iPrint version:$$z9783319475172
000779164 852__ $$bebk
000779164 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-47518-9$$zOnline Access$$91397441.1
000779164 909CO $$ooai:library.usi.edu:779164$$pGLOBAL_SET
000779164 980__ $$aEBOOK
000779164 980__ $$aBIB
000779164 982__ $$aEbook
000779164 983__ $$aOnline
000779164 994__ $$a92$$bISE